Publication:
COVID-19 vaccination may enhance hippocampal neurogenesis in adults

Simple item page
dc.contributor.authorKumar, Ashutosh
dc.contributor.authorNarayan, Ravi K.
dc.contributor.authorPrasoon, Pranav
dc.contributor.authorJha, Rakesh K.
dc.contributor.authorKumar, Sujeet
dc.contributor.authorKumari, Chiman
dc.contributor.authorPandey, Sada N.
dc.contributor.authorFaiq, Muneeb A.
dc.date.accessioned2025-01-28T10:11:36Z
dc.date.available2025-01-28T10:11:36Z
dc.date.issued2023
dc.description.abstractEmerging evidence suggests a detrimental impact of COVID-19 illness on the continued hippocampal neurogenesis in adults. In contrast, the existing literature supports an enhancing effect of COVID-19 vaccination on adult hippocampal neurogenesis. Vaccines against respiratory infections, including influenza, have been shown to enhance hippocampal neurogenesis in adult-age animals. We propose that a similar benefit may happen in COVID-19 vaccinated adults. The vaccine-induced enhancement of the hippocampal neurogenesis in adults thus may protect against age-related cognitive decline and mental disorders. It also hints at an added mental health benefit of the COVID-19 vaccination programs in adults. � 2022 Elsevier Inc.
dc.identifier.doihttps://doi.org/10.1016/j.bbi.2022.09.020
dc.identifier.issn8891591
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/23913
dc.language.isoen
dc.publisherAcademic Press Inc.
dc.subjectAcquired immunity
dc.subjectAdult
dc.subjectCOVID-19 vaccination
dc.subjectHippocampus
dc.subjectNeurogenesis
dc.titleCOVID-19 vaccination may enhance hippocampal neurogenesis in adults
dc.typeReview
dspace.entity.typePublication
journal.titleBrain, Behavior, and Immunity
journalvolume.identifier.volume107

Files

Collections

2023